NO20013168D0 - Nye 7<alfa>, 17<alfa>-bisalkylerte testosteronderivater og anvendelse av disse for langtidsbehandling av androgenavhengigesykdommer - Google Patents

Nye 7<alfa>, 17<alfa>-bisalkylerte testosteronderivater og anvendelse av disse for langtidsbehandling av androgenavhengigesykdommer

Info

Publication number
NO20013168D0
NO20013168D0 NO20013168A NO20013168A NO20013168D0 NO 20013168 D0 NO20013168 D0 NO 20013168D0 NO 20013168 A NO20013168 A NO 20013168A NO 20013168 A NO20013168 A NO 20013168A NO 20013168 D0 NO20013168 D0 NO 20013168D0
Authority
NO
Norway
Prior art keywords
group
membered ring
bond
alfa
long
Prior art date
Application number
NO20013168A
Other languages
English (en)
Other versions
NO20013168L (no
Inventor
Arwed Cleve
Gerhard Sauer
Christoph Huwe
Karsten Parczyk
Jens Hoffmann
Martin Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20013168D0 publication Critical patent/NO20013168D0/no
Publication of NO20013168L publication Critical patent/NO20013168L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20013168A 1998-12-23 2001-06-22 Nye 7<alfa>, 17<alfa>-bisalkylerte testosteronderivater og anvendelse av disse for langtidsbehandling av androgenavhengigesykdommer NO20013168L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19860719A DE19860719A1 (de) 1998-12-23 1998-12-23 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen
PCT/EP1999/010355 WO2000039148A1 (de) 1998-12-23 1999-12-23 Neue 7-alpha, 17-alpha-bis-alkylierte testosteronderivate und ihre verwendung zur langzeittherapie von androgen-abhängigen erkrankungen

Publications (2)

Publication Number Publication Date
NO20013168D0 true NO20013168D0 (no) 2001-06-22
NO20013168L NO20013168L (no) 2001-06-22

Family

ID=7893124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013168A NO20013168L (no) 1998-12-23 2001-06-22 Nye 7<alfa>, 17<alfa>-bisalkylerte testosteronderivater og anvendelse av disse for langtidsbehandling av androgenavhengigesykdommer

Country Status (7)

Country Link
EP (1) EP1140972B1 (no)
JP (1) JP2002533471A (no)
AT (1) ATE233782T1 (no)
AU (1) AU2285800A (no)
DE (2) DE19860719A1 (no)
NO (1) NO20013168L (no)
WO (1) WO2000039148A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049736A1 (de) * 2000-09-29 2002-04-18 Jenapharm Gmbh 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
HUP0302632A2 (hu) * 2001-01-09 2003-11-28 Schering Ag Antigesztagének alkalmazása gyorsított endometriális érés gátlására meddőségi kezelés alatt
US20020143000A1 (en) * 2001-01-09 2002-10-03 Christa Hegele-Hartung Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
CN100396693C (zh) * 2006-11-08 2008-06-25 浙江大学 1,4-孕二烯-16β-甲基-17α,21-二羟基物的制备方法
EP3004013B2 (en) 2013-05-30 2020-11-18 AGC Glass Europe Solar control glazing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
KR0181264B1 (ko) * 1989-07-07 1999-03-20 라브리 페르낭 성스테로이드 활성 억제용 안드로겐 유도체
AU3257993A (en) * 1991-12-22 1993-07-28 Schering Aktiengesellschaft 3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs

Also Published As

Publication number Publication date
DE19860719A1 (de) 2000-06-29
JP2002533471A (ja) 2002-10-08
ATE233782T1 (de) 2003-03-15
AU2285800A (en) 2000-07-31
WO2000039148A1 (de) 2000-07-06
EP1140972B1 (de) 2003-03-05
DE59904499D1 (de) 2003-04-10
EP1140972A1 (de) 2001-10-10
NO20013168L (no) 2001-06-22

Similar Documents

Publication Publication Date Title
CY1119368T1 (el) Νεα παραγωγα αδενινης
ECSP941066A (es) Derivados de 1.5 benzodiazepina
HUP9801711A2 (hu) Helyettesített imidazolidin-2,4-dion-vegyületek felhasználása fájdalomcsillapító szerként alkalmazható gyógyszerkészítmények előállítására
TR200001558T2 (tr) Yeni bileşikler.
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
NO20030471L (no) Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor
EA200000856A1 (ru) Применение бактерий, наделенных аргининдезиминазой, для индукции апоптоза и/или уменьшения воспалительной реакции и фармацевтические или диетические композиции, содержащие такие бактерии
CY1109835T1 (el) Πυρανονες χρησιμες ως αναστολεις της atm
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
DE60002512D1 (de) Aufzeichnungsmaterial sowie Bilddruckverfahren das dieses Material verwendet
HUP0303241A2 (hu) Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek
NO20013168D0 (no) Nye 7&lt;alfa&gt;, 17&lt;alfa&gt;-bisalkylerte testosteronderivater og anvendelse av disse for langtidsbehandling av androgenavhengigesykdommer
ATE24001T1 (de) Substituierte 1-hydroxyethyl-triazolyl-derivate.
FI923514A0 (fi) Herbicider.
BR9814897A (pt) S-óxido e s,s-dióxido de feniloxazolidinonas tetrahidrotiopirano
DE60327922D1 (de) Harnstoff-linker verbindungen und ihre verwendung als ppar regulatoren
DE602005024623D1 (de) Neue betulinsäurederivate kondensiert im a-ring mit einer heterozyklischen gruppe
DE60234117D1 (de) 2-amino-4-pyridylmethyl-thiazolinderivate und ihre verwendung als induzierbare no-synthase inhibitoren
ES2039364T3 (es) Derivados de n - ariltetrahidroftalimida y sus productos previos.
ATE246703T1 (de) Oral wirksame 7-alpha-alkyl androgene
HUP0001397A2 (hu) 3-Amino-3-aril-propán-1-ol-származékok, előállításuk és felhasználásuk
Arava et al. Efficient cyclopropanation of active methylene compounds. A serendipitous discovery
ATE381553T1 (de) Thiocarbonate als vorläufer von aromavermittler
HUP0400733A2 (hu) Új benzilamino-pirimidinek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
AR006205A1 (es) Pirimidilfenileteres y pirimidilbencileteres, procedimientos y productos intermedios para su preparacion y su aplicacion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application